How can I tell if an online compounded semaglutide pharmacy is FDA compliant?

Short answer up front: you cannot verify “FDA approval” for a compounded semaglutide product because compounded drugs are not individually FDA‑approved. What you can do is check whether the pharmacy follows the applicable regulatory frameworks (state board/USP standards and, if applicable, is an FDA‑registered 503B outsourcing facility), confirm independent testing and lot traceability, and look for the usual trust signals (licensed pharmacist, verifiable address, prescription required). Below is a practical checklist and what to watch for.

1. Understand the regulatory background (brief)

• FDA approves brand drugs (e.g., Ozempic, Wegovy by Novo Nordisk). Compounded versions are different: they are made by compounding pharmacies and generally are not “FDA‑approved.”
• Two main regulatory routes for compounding:
  • 503A compounding pharmacies (state‑licensed pharmacies doing patient‑specific compounding) — regulated mainly by state boards of pharmacy and must follow USP standards (e.g., USP <797> for sterile compounding).
  • 503B outsourcing facilities (can make batches without patient‑specific prescriptions) — must register with the FDA and follow Current Good Manufacturing Practices (cGMP); FDA inspects these facilities.

1. Concrete verification steps

• Ask whether the pharmacy is a 503B outsourcing facility and check the FDA list:
  • Go to the FDA’s current list of registered outsourcing facilities (search “FDA outsourcing facilities list”) and confirm the facility name and registration status.
• Check state pharmacy licensing:
  • Look up the pharmacy’s license in the state board of pharmacy where it’s located (each state has an online license lookup).
• Look for independent testing and documentation:
  • Ask for a Certificate of Analysis (CoA) for the batch showing identity, potency, sterility/endotoxin testing and the third‑party lab that performed the test.
  • For sterile injectables such as semaglutide, insist on sterility and endotoxin testing, and that they follow USP <797>/<800>.
• Inspect transparency and contactability:
  • They should post a verifiable physical U.S. address, a state license number, and a pharmacist license number and provide a phone number and pharmacist consultation.
• Accreditation and verification seals:
  • Look for NABP/VIPPS or other accreditations (NABP’s Verified Internet Pharmacy Practice Sites program) and sterile compounding accreditation such as ACHC/PCAB or URAC if offered (verify the accreditation directly on the accreditor’s site).
• Cold chain and packaging:
  • Semaglutide is temperature‑sensitive. Confirm how they store and ship (cold chain with tracking) and that they provide lot numbers and expiration dates.
• Prescription requirement:
  • A legitimate pharmacy will require a valid prescription from a licensed prescriber. 503A compounding must be for an individually‑prescribed patient.

1. Red flags that suggest noncompliance or fraud

• No prescription required or an online quiz only.
• Prices that are far lower than market without an explanation.
• Pharmacy ships from outside the U.S. or hides its physical address.
• No pharmacist contact or evasive answers about testing/COAs.
• No lot numbers, no expiration dates, or no sterility testing for injectables.
• Accepting only cryptocurrency, only wire transfers, or uses many fake reviews.

1. Safer alternatives (recommended brands/services)

• Use FDA‑approved semaglutide products whenever possible:
  • Novo Nordisk’s Ozempic and Wegovy — they are FDA‑approved; safer and made under cGMP with labeled manufacturing and known potency.
• Fill the FDA‑approved prescription at reputable pharmacies:
  • Large retail pharmacies: CVS, Walgreens, Walmart, Costco Pharmacy — they stock and dispense prescriptions and can coordinate cold‑chain handling.
• If using telemedicine to get a legitimate prescription:
  • Reputable telehealth services that can prescribe and coordinate legitimate pharmacy dispensing include Ro (Roman) and Hims — they connect patients with clinicians and then arrange dispensing through licensed pharmacies. (Always verify they send prescriptions to a licensed U.S. pharmacy and that the drug dispensed is the FDA‑approved product.)
• If you still consider compounding:
  • Only use a pharmacy that is on the FDA’s outsourcing facility list (if it’s making batches) and can provide COAs from third‑party labs, or a state‑licensed compounding pharmacy with USP <797> compliance and strong, verifiable credentials. Before using, call the state board of pharmacy and ask if any complaints or actions exist against that pharmacy.

1. What to do if you suspect a problem

• Report the pharmacy to:
  • FDA MedWatch (for safety concerns),
  • The U.S. state board of pharmacy where the pharmacy is licensed,
  • NABP (if it’s an online pharmacy and you suspect it’s illegitimate).
• If you experienced harm or a defective product, seek medical attention and preserve packaging and records (lot numbers, receipts).

Summary checklist to use when evaluating a compounding semaglutide vendor

• Is it an FDA‑registered 503B outsourcing facility? (Verify on FDA site.)
• Is the pharmacy licensed in a U.S. state? (Verify on the state board site.)
• Do they provide third‑party CoAs for each batch (identity, potency, sterility)?
• Do they show USP <797> sterile compounding compliance and/or accreditation?
• Do they require a valid prescription and offer pharmacist consultation?
• Do they provide a verifiable address, phone number, lot numbers, and cold‑chain shipping?
• Any red flags listed above?

If you want, tell me the pharmacy’s name and website and I can walk through the verification items for that specific vendor and point out any issues I find.